Last week, readers were most interested in a story about Achieve Diagnostics buying the pharmacogenomic assets of H&M Molecular Diagnostics.

The firm currently offers its HerResolve multiomic test for endometriosis that looks at seven biomarkers, including microRNAs ...

The company will conduct a prospective, multicenter study enrolling approximately 954 men with elevated PSA levels who are scheduled for a prostate biopsy.

The planned trial will investigate Eledon's tegoprubart, a therapy designed to prevent organ rejection in kidney transplantation.

The agency cleared more than a dozen assays and instruments for microbiology, molecular biology, clinical chemistry, and other testing.

Verici Dx said on Wednesday that its Tutivia lab-developed test for acute kidney transplant rejection risk has been approved by the New York State Department of Health (NYSDOH). With the approval ...

The Germany-based company is developing a handheld infectious disease testing platform that does not require electricity.

NEW YORK – Alzheimer's diagnostic company Alzpath announced on Wednesday that it has signed a global licensing agreement with Abbott to develop blood-based tests for Alzheimer's disease. Financial and ...

NEW YORK – French oncology diagnostics company Spotlight Medical announced on Tuesday that its MyStage Dx assay for breast cancer has received CE marking under Europe's In Vitro Diagnostic Regulation.

Last week, readers were most interested in a story about an allegation that Invitae illegally shared patients' genetic data.

The guidelines state that a test must be FDA-approved, personalized, tumor-informed, multiplex, and use PCR-NGS for ctDNA.